Latest news
Sionna Therapeutics stock plunges nearly 100% after cystic fibrosis drug fails key trial - The Business JournalsThe Business Journals · Mon, 10 Aug 2026 16:58:00 GMTSionna cystic fibrosis drug fails key trial, removing threat to Vertex - BioPharma DiveBioPharma Dive · Mon, 10 Aug 2026 16:27:14 GMTSionna’s experimental cystic fibrosis pill falls flat in mid-stage trial - STATSTAT · Mon, 10 Aug 2026 15:34:15 GMTWeight gain linked to lower inflammation in children with CF - Cystic Fibrosis News TodayCystic Fibrosis News Today · Mon, 10 Aug 2026 14:15:18 GMTSionna Therapeutics' cystic fibrosis drug trial fails, shares drop sharply amid investigation. - PluangPluang · Mon, 10 Aug 2026 13:59:57 GMTSionna Therapeutics shares collapse 92% after cystic fibrosis trial misses key endpoint - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 12:48:07 GMTSionna Won’t Advance Add-On Drug After CF Trial Misses Goal - Stock TitanStock Titan · Mon, 10 Aug 2026 11:00:00 GMTSionna Therapeutics Reports Topline Data from Two Development Programs in Cystic Fibrosis and Provides Corporate Update - Carroll County Mirror-DemocratCarroll County Mirror-Democrat · Mon, 10 Aug 2026 11:00:00 GMT